arrow
F

Fiorella Calabrese

university of padova medical school
H指数:56
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Artificial intelligence-based assessment of tumor bed stroma in non-small cell lung cancer after neoadjuvant therapy: Association with pathologic response and survival. A multicenter study

基于人工智能对非小细胞肺癌新辅助治疗后肿瘤床间质的评估:与病理反应和生存期的关联。一项多中心研究

2026-09-010
PRE
From fragmentation to focus: building collaborative networks for rare cancer research – the Italian TYME network as a model for care and innovation?

从碎片化到聚焦:构建罕见癌症研究的协作网络——意大利TYME网络是否为护理与创新提供了范例?

2026-08-250
PRE
Revised demicco score improves prediction of postoperative recurrence in pleural solitary fibrous tumours: A multicenter retrospective study

修订后的demicco评分提高了胸膜孤立性纤维瘤术后复发的预测:一项多中心回顾性研究

EJSO
IF2.9
2026-08-010
PRE
Pathologic Evaluation of Pig Kidney and Heart Xenografts: 2024 Recommendations from the Banff Xenotransplantation Pathology Working Group

猪肾脏和心脏异种移植物病理学评估:2024年巴夫异种移植病理学工作组建议

2026-04-140
OAAI
Considerations for Endpoints in Lung Transplant Clinical Trials: Perspective on the ISHLT Consensus Statement

肺移植临床试验终点的考虑因素: ISHLT共识声明的观点

2026-01-160
PRE
Considerations for Endpoints in Lung Transplant Clinical Trials: An ISHLT Consensus Statement

肺移植临床试验终点选择的考量:一项国际心肺移植学会(ISHLT)共识声明

2025-12-160
PRE
Pathologic assessment of resected stage III non-small cell lung cancer after neoadjuvant chemotherapy: identification of additional prognostic factors

III期非小细胞肺癌新辅助化疗后切除标本的病理评估:识别额外的预后因素

2025-11-090
OAAI
Diagnostic significance of intragraft donor-specific anti-HLA antibodies in pulmonary antibody-mediated rejection

移植肺内供者特异性抗-HLA抗体的诊断意义

2025-08-210
PRE
International guidelines on the diagnosis and treatment of NUT carcinoma

NUT癌的诊断与治疗国际指南

2025-07-310
OAAI
Surgery for Pancoast Tumors in Multimodality Setting: Analysis of Outcomes and Risk Factors

多模式治疗环境下Pancoast肿瘤的手术治疗:结局与危险因素分析

2025-04-170
OA
Liver kinase B1 expression is associated with improved prognosis and tumor immune microenvironment features in small cell lung cancer
2025-04-040
OAAI
EGFR status assessment using reflex testing targeted next-generation sequencing for resected non-squamous non-small cell lung cancer
2024-12-311
PRE